Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-31, Stock:PFE, The news for the past five days is as follows:
2018-08-24: NEWS1: Analyzing AstraZeneca’s Financial Performance.NEWS2: Analysts Are Bullish on AstraZeneca Stock in August.NEWS3: Merck, Pfizer to Benefit From Pharma Surge: MS.NEWS4: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS5: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS6: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS7: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS8: Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs.NEWS9: Exact Sciences Revisited.NEWS10: Exact Sciences Revisited.
2018-08-27: NEWS1: EIDX Awaits Phase II Data, PTX Slumps On Court Ruling, TOCA On Watch.NEWS2: EIDX Awaits Phase II Data, PTX Slumps On Court Ruling, TOCA On Watch.NEWS3: What Happened in the Stock Market Today.NEWS4: What Happened in the Stock Market Today.NEWS5: All-Time highs: 6 stocks to buy.NEWS6: Nasdaq Tops 8K as Stocks Celebrate U.S.-Mexico Trade Deal.NEWS7: Nasdaq Tops 8K as Stocks Celebrate U.S.-Mexico Trade Deal.NEWS8: Why Pfizer (PFE) Stock Turned South Today.NEWS9: TLRY On Fire, CRON Up 94% This Month, ALNY Abuzz, RCUS Turns Heads.NEWS10: TLRY On Fire, CRON Up 94% This Month, ALNY Abuzz, RCUS Turns Heads.NEWS11: What Happened in the Stock Market Today.NEWS12: General Motors and Caterpillar jump; Tesla and Pfizer skid.NEWS13: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS14: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS15: Pfizer Slips Despite Mostly Positive Tafamidis Data; 4 Pharma Stocks Make Sympathy Moves.NEWS16: Here's Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS17: Here's Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS18: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS19: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS20: Here&apos;s Why Alnylam Pharmaceuticals and Ionis Pharmaceuticals Jumped Today.NEWS21: Dow Movers: PFE, CAT.NEWS22: Dow Movers: PFE, CAT.NEWS23: Pfizer rare-disease drug results lift its shares and those of rival.NEWS24: US STOCKS-Futures rise as trade tensions ease.NEWS25: What AstraZeneca’s Valuation Trend Indicates.NEWS26: Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018.NEWS27: Pfizer's Potential Blockbuster Heart Drug Boosted by Study.NEWS28: Pfizer rare heart disease drug reduces risk of death by 30 pct in study.NEWS29: EpiPen Shortage Hits Back-to-School Season.
2018-08-28: NEWS1: 3 ETFs for Johnson & Johnson's Healthy Breakout.NEWS2: Pfizer Recalls Children's Advil Recall Due To Overdose Concerns.NEWS3: Pfizer Recalls Children's Advil Recall Due To Overdose Concerns.NEWS4: Why Ionis Pharmaceuticals Stock Is Plummeting Today.NEWS5: Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS6: Pfizer's Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS7: Notable ETF Inflow Detected - IWB, UNH, PFE, CVX.NEWS8: Notable ETF Inflow Detected - IWB, UNH, PFE, CVX.NEWS9: 6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug.NEWS10: 6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug.NEWS11: Pfizer&apos;s Tafamidis Fails to Impress in Cardiomyopathy Study.NEWS12: This Is Like Buying in March 2009 and Knowing What Happens Next.NEWS13: This Is Like Buying in March 2009 and Knowing What Happens Next.NEWS14: 6 Things Alnylam Investors Need to Know About Pfizer&apos;s Next Blockbuster Drug.NEWS15: Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors.NEWS16: Why Alnylam Pharmaceuticals Stock Rose ~16% Yesterday.NEWS17: Today’s Research Reports on Stocks to Watch: Pfizer and Alnylam Pharmaceuticals.NEWS18: Why Pfizer (PFE) Stock Turned South Today.NEWS19: Why Pfizer (PFE) Stock Turned South Today.
2018-08-29: NEWS1: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS2: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS3: Canadian Trade Hopes, Tech Push Nasdaq, S&P to Record Highs.NEWS4: Canadian Trade Hopes, Tech Push Nasdaq, S&P to Record Highs.NEWS5: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS6: EC Approves Amgen’s Blincyto for Pediatric Patients.NEWS7: Pfizer Stock Up This Year So Far: What's Going in its Favor?.NEWS8: Pfizer Stock Up This Year So Far: What's Going in its Favor?.NEWS9: Pfizer Stock Up This Year So Far: What&apos;s Going in its Favor?.NEWS10: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 30, 2018.NEWS11: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 30, 2018.
2018-08-30: NEWS1: CRON Goes Up In Smoke On Citron Report, Hot AFMD Is Cooling Now, REPL On Watch.NEWS2: CRON Goes Up In Smoke On Citron Report, Hot AFMD Is Cooling Now, REPL On Watch.NEWS3: U.S. Stocks Snap Four-Day Win Streak on Renewed China Trade Concerns.NEWS4: U.S. Stocks Snap Four-Day Win Streak on Renewed China Trade Concerns.NEWS5: Pfizer’s Quarterly Revenues and Estimates for 2018.NEWS6: Pfizer’s Developments in August.NEWS7: Pfizer (PFE) Up 3.1% Since Last Earnings Report: Can It Continue?.NEWS8: Pfizer (PFE) Up 3.1% Since Last Earnings Report: Can It Continue?.NEWS9: Pfizer’s Stock Performance in August.NEWS10: Scholar Rock stock tumbles 11% as Pfizer discontinues similar medication.NEWS11: Pfizer (PFE) Up 3.1% Since Last Earnings Report: Can It Continue?.NEWS12: Dow Movers: DWDP, PFE.NEWS13: Dow Movers: DWDP, PFE.NEWS14: Amgen&apos;s Leukemia Drug Blincyto Gets EU Nod for Pediatric Use.NEWS15: Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?.NEWS16: Pfizer stops developing therapy for the rare disease Duchenne muscular dystrophy.NEWS17: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS18: Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy.NEWS19: 3 High-Yield Healthcare Dividend Stocks Still Worth Buying.NEWS20: 3 High-Yield Healthcare Dividend Stocks Still Worth Buying.NEWS21: Pfizer Terminates Two Duchenne Muscular Dystrophy Studies.NEWS22: Pfizer Terminates Two Duchenne Muscular Dystrophy Studies.

Answer: Rise